Citing additional data from the Ovarian Cancer Association Consortium, the authors hypothesize that BRCA2 K3326X is likely a low risk allele for ovarian cancer with an OR of 1.22–9.3. The gene discussed is BRCA2; the disease is ovarian carcinoma.